Clinic days often hinge on one question patients ask with a mix of hope and hesitation: is there a pill that can match the clearing power of injections without the needles, the storage hassles, or the crowded appointment calendar. That answer just shifted as the FDA cleared Johnson & Johnson’s
Ivan Kairatov brings a biopharma lens to clinician-AI collaboration, blending R&D rigor with practical know‑how from tech-enabled trials. In recent studies, chatbots not only matched but sometimes outperformed clinicians on management reasoning tasks, especially when teams used deliberate workflows
Relentless rises in drug-resistant infections have turned routine care into a negotiation with risk that standard antibiotics too often lose, and the search for smarter countermeasures has shifted to tools built by biology itself. Bacterial extracellular vesicles (BEVs) sit at that inflection
The choice happens in a blink—flavored yogurt cup or plain yogurt with a drizzle of maple syrup—yet the metabolic ripples from that small moment could touch cholesterol, blood pressure, and insulin sensitivity before the month is out, and for millions such split-second picks may shape a decade of
The diagnostic weight of Glioblastoma Multiforme has remained largely unchanged for decades, despite the rapid acceleration of genetic sequencing and molecular mapping in other oncology sectors. This malignancy represents the primary challenge in adult oncology due to its infiltrating nature and
The warming of coastal waters along the Atlantic and Mediterranean has accelerated the proliferation of Vibrio bacteria, creating an urgent public health crisis that demands immediate scientific intervention. As these pathogens thrive in rising temperatures, traditional medical approaches find
